Klinefelter Syndrome Clinical Trial
— KLIN-HEALTHOfficial title:
Dissecting the Importance of Sex Steroids Balance for Metabolic and Reproductive Health in Men With Klinefelter Syndrome: a Randomized Controlled Study
The study seeks primarily to determine whether modulation of systemic and testicular sex steroids balance by aromatase inhibitors will positively affect the metabolic health and spermatogenesis of men with Klinefelter syndrome (KFS) as compared to the current state of the art for each issue. Secondary objectives of this study are (i) to unravel the heterogeneity of the reproductive and metabolic phenotype of men with KFS by performing a multi-omic analysis in a large cohort at baseline; (ii) to evaluate the efficacy of semaglutide-induced weight loss to achieve metabolic and reproductive benefit in men with Klinefelter syndrome as compared to standard testosterone replacement; (ii) to assess whether addition of hCG to aromatase inhibitors further increases intratesticular testosterone and promotes spermatogenesis in men with KFS.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | April 1, 2026 |
Est. primary completion date | April 1, 2026 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 16 Years to 65 Years |
Eligibility | Inclusion Criteria: -Diagnosis of Klinefelter syndrome (47,XXY or mosaicism) Design 1: - Age range: 16-40 years old - Intention to become parent or interest in fertility preservation - Confirmed azoospermia (lack of spermatozoids) after centrifugation of one semen sample Design 2: - Age range: 18-65 years old - No interest in fertility or fertility preservation - Hypogonadism at diagnosis or after wash-out of testosterone replacement therapy - High metabolic risk defined as overweight (BMI 25-28 kg/m2) and insulin resistance (HOMA-IR > 2.6) Exclusion Criteria: - Contraindications to testosterone-rising therapies (prostate or breast cancer, PSA > 4 µg/l, active liver disease, symptomatic heart disease) - Decreased life expectancy due to terminal disease - Known or suspected non-compliance, drug or alcohol abuse - Inability to follow the procedures of the study (language problems, severe psychological or mental disorders) |
Country | Name | City | State |
---|---|---|---|
Switzerland | Service of Endocrinology, Diabetes & Metabolism | Lausanne |
Lead Sponsor | Collaborator |
---|---|
Georgios Papadakis |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Design 1 : sperm retrieval rate at mTESE biopsy | Sperm retrieval rate at mTESE biopsy (Group A and B) | mTESE biopsy 26 weeks after hormonal intervention | |
Primary | Design 2 : change in insulin resistance index (HOMA-IR) | HOMA-IR calculated using fasting glucose and insulin levels | From baseline to week 26 of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03396562 -
The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy
|
||
Completed |
NCT02526628 -
Thrombosis and Neurocognition in Klinefelter Syndrome
|
||
Completed |
NCT01690013 -
Life Quality and Health in Patients With Klinefelter Syndrome
|
N/A | |
Completed |
NCT01678261 -
X-chromosome Inactivation, Epigenetics and the Transcriptome
|
N/A | |
Completed |
NCT01918280 -
Fertility Preservation in Cases of Klinefelter Syndrome.
|
N/A | |
Completed |
NCT02787486 -
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
|
||
Completed |
NCT03325647 -
TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY
|
Phase 4 | |
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Recruiting |
NCT05498090 -
Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome
|
Phase 4 | |
Completed |
NCT00999310 -
Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome
|
N/A | |
Completed |
NCT02408445 -
Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment
|
Phase 4 | |
Completed |
NCT00896272 -
Adaptation Among Adolescents and Adults With Klinefelter Syndrome
|
||
Completed |
NCT02723305 -
Cardiometabolic Profiles of Boys With Klinefelter Syndrome
|
||
Completed |
NCT05581147 -
Thyroid Function and Structure IN Klinefelter Syndrome
|
||
Active, not recruiting |
NCT02430584 -
Whole Blood Specimen Collection From Pregnant Subjects
|
||
Completed |
NCT01817296 -
Klinefelter Fertility Preservation
|
N/A | |
Completed |
NCT01585831 -
Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome
|
N/A | |
Completed |
NCT01206270 -
Androgen for Leydig Cell Proliferation
|
Phase 2/Phase 3 | |
Withdrawn |
NCT00347464 -
Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome
|
N/A | |
Recruiting |
NCT05425953 -
Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype
|